Published: 19 June 2020
Journal: Journal of Clinical Immunology
Summary: A CTLA4 haploinsufficient patient with cryptic splice site mutation who presented with classical Kaposi’s sarcoma and the therapeutic response to targeted therapy with Everolimus
Take Home Message: Low-dose sirolimus and everolimus can reprogram exhausted T cells and recalibrate anti-viral and anti-cancer immunity